Todd Brown, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu
  • Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
  • Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
  • Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  • Protocol Vice-Chair, ACTG 5280, ACTG 5303
  • Co-chair, ACTG 5361s
  • Co-investigator, ACTG 5257

Categories

Leadership Committees
CRS
Roles

Clinical Trials

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5300B/I2003B/PHOENIX, Protecting Households On Exposure to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

Read More

Impact of Tuberculosis Infection on HIV-1 Antibody Response...

Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...

Read More

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More